- Home
- VAC vs CPRX Comparison
VAC vs CPRX Comparison
Compare VAC & CPRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VAC
- CPRX
- Stock Information
- Founded
- VAC 1984
- CPRX 2002
- Country
- VAC United States
- CPRX United States
- Employees
- VAC N/A
- CPRX N/A
- Industry
- VAC Real Estate
- CPRX Biotechnology: Pharmaceutical Preparations
- Sector
- VAC Finance
- CPRX Health Care
- Exchange
- VAC Nasdaq
- CPRX Nasdaq
- Market Cap
- VAC 2.7B
- CPRX 2.8B
- IPO Year
- VAC N/A
- CPRX 2006
- Fundamental
- Price
- VAC $94.10
- CPRX $21.48
- Analyst Decision
- VAC Buy
- CPRX Strong Buy
- Analyst Count
- VAC 10
- CPRX 7
- Target Price
- VAC $98.05
- CPRX $31.14
- AVG Volume (30 Days)
- VAC 446.7K
- CPRX 1.1M
- Earning Date
- VAC 11-06-2024
- CPRX 11-06-2024
- Dividend Yield
- VAC 3.23%
- CPRX N/A
- EPS Growth
- VAC N/A
- CPRX 114.68
- EPS
- VAC 5.26
- CPRX 1.18
- Revenue
- VAC $3,194,000,000.00
- CPRX $460,482,000.00
- Revenue This Year
- VAC $54.30
- CPRX $21.99
- Revenue Next Year
- VAC $4.79
- CPRX $17.95
- P/E Ratio
- VAC $17.89
- CPRX $18.22
- Revenue Growth
- VAC N/A
- CPRX 32.17
- 52 Week Low
- VAC $67.28
- CPRX $13.00
- 52 Week High
- VAC $108.57
- CPRX $24.27
- Technical
- Relative Strength Index (RSI)
- VAC 68.57
- CPRX 48.92
- Support Level
- VAC $88.30
- CPRX $20.87
- Resistance Level
- VAC $94.94
- CPRX $21.63
- Average True Range (ATR)
- VAC 2.87
- CPRX 0.77
- MACD
- VAC -0.01
- CPRX -0.22
- Stochastic Oscillator
- VAC 73.30
- CPRX 27.15
About VAC Marriott Vacations Worldwide Corporation
Marriott Vacations Worldwide Corp functions in the United States leisure industry. It owns and manages a cluster of resorts and accommodation facilities under trademarks like Marriott Vacation Club, Grand Residencies, and The Ritz-Carlton Destination Club predominantly in the United States. Some of its properties are also spread across Europe and Asia Pacific. Marriott's majority revenue components include the sale of vacation ownership products such as luxurious vacation packages. In addition, it offers purchase money financing to the end users of its core services. The company operates in two reportable segments: Vacation Ownership and Exchange & Third-Party Management. The majority of revenue is derived from the Vacation Ownership segment.
About CPRX Catalyst Pharmaceuticals Inc.
Catalyst Pharmaceuticals Inc is a biopharmaceutical company. It focuses on developing and commercializing, developing therapies for people with rare, debilitating, chronic neuromuscular and neurological diseases. It offers Firdapse, a proprietary form of amifampridine phosphate for the treatment of patients with Lambert-Eaton myasthenic syndrome.